HEXO Corp

HEXO Corp. engages in the provision of cannabis and cannabis products. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hydropothecary is a licensed producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations.Their leadership team brings proven scientific, financial, regulatory and entrepreneurial expertise to the rapidly evolving Canadian medical marijuana industry.Hydropothecary is an award-winning medical cannabis producer located on a 143-acre farm in Gatineau, Quebec, in the National Capital Region. Their focus is on product innovation, advanced natural growing techniques, client health and safety, and exceptional customer service. They take their commitment to customers seriously, offering exceptional packaging, courier delivery in Canada (Saturdays where available) and their bilingual, 24-hour customer service.

HEXO Corp. (HEXO) CEO Scott Cooper on Q2 2022 Results - Earnings Call Transcript

Company makes significant progress on capital structure and strengthening balance sheet. Company makes significant progress on capital structure and strengthening balance sheet.

HEXO Reports Second Quarter 2022 Results, Embarks on Transformative Plan

HEXO stock has the combined risks of being a penny stock, with a delisting on the table, topped off by poor fundamentals. Best to avoid.

HEXO Has Too Many Risks Right Now

Tilray Brands

Shareholders are now getting a two-companies-for-the-price-of-one deal with TLRY stock, but whether that's a good or not thing is debatable. The post If You're Going to Hold Tilray Stock, You'd Better Be a Fan of Hexo Too appeared first on InvestorPlace.

If You're Going to Hold Tilray Stock, You'd Better Be a Fan of Hexo Too

This news release constitutes a “designated news release” for the purposes of the Company's prospectus supplement dated May 11, 2021 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021.

HEXO Announces High Trail Waives Event of Default Under Secured Note

A day after Tilray Inc (NASDAQ: TLRY) announced a strategic partnership with Hexo Corp (TSE: HEXO), Canaccord Genuity upgraded both cannabis companies to “buy”. How does the deal benefit Tilray stock?

Tilray stock: Canaccord Genuity sees a 75% upside

Tilray is acquiring a portion of Hexo's debt. Here's what investors in HEXO, TLRY stocks should know about the collaboration between the two.

HEXO, TLRY Stocks: 8 Things to Know About the New Deal Linking Hexo and Tilray

Two Canadian cannabis companies are entering into a new strategic alliance.

Why Hexo Shares Soared Today

HEXO Corp (NASDAQ: HEXO) is trading higher Thursday after the company announced a strategic partnership with Tilray Brands Inc (NASDAQ: TLRY) which includes a new debt financing agreement. Under the new agreement, Tilray will acquire $211 million of senior secured convertible.

Why HEXO Shares Are Trading Higher Today

Tilray Brands on Thursday agreed to buy up to $211 million of HEXO's debt, giving the Canadian cannabis producer a right to pick a significant equity stake in its troubled rival.

Cannabis producer Tilray to buy rival HEXO's debt of up to $211 million

Tilray Brands Inc. TLRY, -0.34% TLRY, -1.34% said Thursday it would buy up to C$211 million ($167 million) of Hexo Corp. HEXO, +5.82% HEXO, +4.29% senior secured convertible notes held by HT Investments MA LLC as part of a strategic alliance between the two cannabis companies. Tilray would have the right to convert the debt into stock at a price of 90 cents per Hexo share.

Tilray agrees to buy up to $C211 mln in Hexo debt

HEXO to Restructure Balance Sheet, Including Sale of Amended Senior Secured Convertible Notes to Tilray Brands, Significantly Improving Flexibility and Reinvigorating HEXO's Path Forward Strategy HEXO to Restructure Balance Sheet, Including Sale of Amended Senior Secured Convertible Notes to Tilray Brands, Significantly Improving Flexibility and Reinvigorating HEXO's Path Forward Strategy

HEXO and Tilray Brands Agree to Create Strategic Alliance Bringing Together Two Canadian Cannabis Leaders

Arena Pharmaceuticals

Clever Leaves Holdings Inc

Flora Growth Corp

High Tide

FSD Pharma

Innovative Industrial Properties

22nd Century Group

cbdMD Inc

WM Technology

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.

11 Marijuana Stocks on Fire to Close February

GATINEAU, Quebec, Feb. 22, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company") earlier today announced its refreshed Board of Directors (“Board”). The Company would like to extend heartfelt thanks to John Bell, Adam Miron, Emilio Imbriglio, and Vincent Quan for their loyal service to HEXO. The Company has issued the following statement:

HEXO thanks departing directors for their service to the Company

Canadian pot producer HEXO Corp said on Tuesday it would refresh its board, effective immediately, as part of a deal with activist shareholder Adam Arviv and his fund, Kaos Capital.

Pot producer HEXO to revamp board on activist investor push

GATINEAU, Quebec, Feb. 22, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company") today announced that it has entered into a transition agreement (the “Agreement”) with Adam Arviv and his fund, Kaos Capital, to refresh the Company's board of directors (the “Board”), effective immediately. The new Board will stand for election at the Company's upcoming annual and special meeting of shareholders to be held on March 8, 2022 (the “Meeting”).

HEXO Announces Refreshed Board of Directors; Reaches Agreement with Adam Arviv

Aurora Cannabis

Canopy Growth

Legalization. It's not just for marijuana anymore.

Why Marijuana Stocks Got Stubbed Out Today

Top Pot Stocks To Watch On The Nasdaq The post Top Canadian Marijuana Stocks To Buy? 3 To Watch Now In February 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Buy? 3 To Watch Now In February 2022

OrganiGram Holdings Inc.

Canadian marijuana stocks are reversing course Monday after last week's industrywide surge higher.

Why Canopy Growth, Hexo, and OrganiGram Are Slumping Today

CEA Industries

Leafly Holdings

Neptune Wellness Solutions Inc.

Catch Up On the Busiest Week For Cannabis Stocks of 2022

Here Are 2 Top Marijuana Stocks To Keep An Eye On This Year The post Marijuana Stocks To Watch Moving Further Into 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Marijuana Stocks To Watch Moving Further Into 2022

Hexo Corp HEXO, a leading producer of high-quality cannabis products, is cutting 180 jobs, as part of the Canadian company's cost-cutting plan, resulting in annual savings of approximately $15 million on an annualized basis. Half of these positions are related to the previously announced closure of its Stellarton facility.

Hexo Cuts 180 Jobs As Part Of "Path Forward" And $15M Cost Savings

Hexo Corp. HEXO, +6.49% said Wednesday it is cutting 180 jobs, as part of the Canada-based cannabis company's cost-cutting plan. The layoffs represent about 14% of the company's workforce, which was about 1,277, according to the latest FactSet data.

Cannabis company Hexo to cut 180 jobs

HEXO Provides Update on "The Path Forward"; Identifies $15 Million in Cost Savings

The clock has begun ticking down on this pot stock.

News for HEXO Corp Stock (HEXO)